Sebastien Maloveste

Corporate Officer/Principal at NEXTCURE, INC.

Health Technology

Consumer Services

Profile

Sebastien Maloveste is currently working as the Senior Vice President-Business Development at NextCure, Inc. Previously, he held positions as the Director-Business Development at GenVec, Inc. and as the Associate Director-Business Development at Amplimmune, Inc. Dr. Maloveste obtained a doctorate degree from Universite De La Mediterranee.

Sebastien Maloveste active positions

Companies	Position	Start
NEXTCURE, INC.	Corporate Officer/Principal	-

All active positions of Sebastien Maloveste

Former positions of Sebastien Maloveste

Companies	Position	End
Amplimmune, Inc. Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	-
GENVEC INC	Corporate Officer/Principal	-

See the detail of Sebastien Maloveste's experience

Training of Sebastien Maloveste

Universite De La Mediterranee

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sebastien Maloveste's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NEXTCURE, INC.	Health Technology

Private companies	2
GenVec, Inc. GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD.	Health Technology
Amplimmune, Inc. Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.	Health Technology